AdvaMed seal of approval
This article was originally published in The Gray Sheet
Executive Summary
Trade association announces availability of its "Code of Ethics" logo June 20. With a CEO signature indicating compliance with AdvaMed's code of ethics on interactions with healthcare professionals, device firms may license the "seal of approval" for use on websites, business cards and other marketing materials. The one-year, renewable license agreement has a series of conditions that align with the Office of Inspector General's standards on effective compliance programs (1"The Gray Sheet" March 6, 2006, p. 5)...
You may also be interested in...
AdvaMed Calls For Guidance On Physician Investment In Device Firms
AdvaMed is soliciting guidance from the HHS Office of Inspector General (OIG) regarding potentially unlawful arrangements between device manufacturers and physicians
AdvaMed Plans New “Seal Of Approval” For Firms That Abide By Ethics Code
AdvaMed is planning a program whereby device firms could self-certify that they follow the association's code of ethics on interactions with healthcare professionals
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.